The global rat model market size is expected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising development of new medical devices and growing number of new players initiating innovating healthcare solutions.
A rat model is an experimental method to analyze the effects of Hb and hypoxia on pulmonary hypertension. The model has been widely adopted for various biomedical research to understand the pathogens of several diseases and examine the effectiveness of clinical drugs for the disease prevention. The increasing number of new players coming in the market with innovative healthcare solutions is attributed to fuel the demand for preclinical testing. Mice and rats are commonly used rodents for laboratory testing.
The rat genome is quite similar to that of human i.e. over 24,000 genes are comparable to humans. That is the reason why it is considered to be an ideal experimental animal according to the data published by Human Genome Project. The laboratory rat has contributed significantly to the field of medical research for several indications development of diseases. This market is expected to observe direct competition of mice-based models, those are preferred over rats.
Market Trends, Drivers, Restraints, and Opportunities
- Growing development of new innovative medical devices and biotechnological products is attributed to boost the market growth.
- Rapid expansion of the clinical laboratory test and development of products with new healthcare solutions are expected to promote the growth of the market.
- Wide adoption of rodents for various medical laboratory testing of new experiments, which is further expected to fuel the market growth.
- The presence of genetic variation among the strain and providing multiple services along with breeding for instance quarantine facility are expected to promote the growth of other segments.
- Increasing number of adoption of new technology and innovative products is expected to promote market growth.
Scope of the Report
The report on the global rat model market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Rat Model Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Types (Outbred, Knockout, Inbred, Immunodeficient, Hybrid, and Conditioned), Technology (Microinjection, Nuclear Transferase, Embryonic Stem Cell, and Others), Services (Breeding, Cryopreservation, Genetic Testing, Rederivation, Quarantine Depending, and Others), Applications (Neurology, Oncology, Toxicology, Immunology, and Others), and End-users (Academic and Research Facility, CROs, and Healthcare Companies)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Charles River Laboratories International, Inc.; genOway S.A.; Covance Inc.; Horizon Discovery Group plc.; Envigo; Janvier Labs; Biomedical Research Models (Biomere); and Taconic Biosciences, Inc.
|
Market Segment Insights
Immunodeficient segment is expected to grow at a rapid pace
Based on types, the global rat model market is divided into outbred, knockout, inbred, immunodeficient, hybrid, and conditioned. The immunodeficient segment accounted for a key share of the market in 2019 and is expected to grow at a rapid pace during the projected period owing to the wide variety of rat models available in the market. However, the outbred segment is anticipated to expand at a robust growth rate during the forecast period due to the presence of genetic variation among the strain.
Microinjection segment is projected to expand at a considerable CAGR
On the basis of technology, the market is segmented into microinjection, nuclear transferase, embryonic stem cell, and others. The microinjection segment is projected to expand at a considerable CAGR during the forecast period due to the rising adoption and awareness on microinjection. Meanwhile, the others segment is anticipated to expand at a rapid pace during the forecast period as the need for conditioned and genetically modified animals is rising.
Breeding segment is expected to expand at a robust growth rate
Based on services, the global rat model market is classified into breeding, cryopreservation, genetic testing, rederivation, quarantine depending, and others. The breeding segment is expected to expand at a robust growth rate during the projected period as multiple services are provided along with breeding such as quarantine facility. On the other hand, the others segment is anticipated to expand at a rapid pace during the forecast period due to the rising research and development activities by major market players.
Toxicology segment is expected to register a high CAGR
In terms of applications, the market is segregated into neurology, oncology, toxicology, immunology, and others. The toxicology segment is expected to register a high CAGR during the forecast period due to the presence of various contract research organizations for testing and safety evaluation. The neurology segment, however, is anticipated to expand at a rapid pace during the forecast period owing to rising incidences of diseases such as Parkinson’s disease and stroke.
Healthcare companies segment is expected to account for a key market share
Based on end-users, the global rat model market is divided into academic & research facility, CROs, and healthcare companies. The healthcare companies segment is expected to account for a key share of the market during the targeted period due to increasing number of innovative activities related to the healthcare industry. However, the academic & research facility segment is anticipated to expand at a rapid pace during the forecast period owing to increasing outsourcing research activities.
North America is anticipated to constitute a key market share
In terms of regions, the global rat model market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to constitute a key market share during the projected period due to rising incidences of introduction of new infectious strains and chronic conditions in the region. The market of Asia Pacific, however, is anticipated to expand at a rapid pace during the forecast period as emerging economies in this region are promoting the growth of the rat model industry.
Segments
Segments Covered in the Report
The global rat model market has been segmented on the basis of
Types
- Outbred
- Knockout
- Inbred
- Immunodeficient
- Hybrid
- Conditioned
Technology
- Microinjection
- Nuclear Transferase
- Embryonic Stem Cell
- Others
Services
- Breeding
- Cryopreservation
- Genetic Testing
- Rederivation
- Quarantine Depending
- Others
Applications
- Neurology
- Oncology
- Toxicology
- Immunology
- Others
End-users
- Academic & Research Facility
- CROs
- Healthcare Companies
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Charles River Laboratories International, Inc.
- genOway S.A.
- Covance Inc.
- Horizon Discovery Group plc.
- Envigo
- Janvier Labs
- Biomedical Research Models (Biomere)
- Taconic Biosciences, Inc.
Competitive Landscape
Key players competing in the global rat model market are Charles River Laboratories International, Inc.; genOway S.A.; Covance Inc.; Horizon Discovery Group plc.; Envigo; Janvier Labs; Biomedical Research Models (Biomere); and Taconic Biosciences, Inc. The main market players are continuously indulged in the business development activities such as mergers and acquisitions, research and developments, investments for innovative products and collaborations to enhance their market positions.
Request For Customization
Enquiry Before Buying
Speak With Analyst
